147 related articles for article (PubMed ID: 9064355)
61. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling.
Linsley PS; Bradshaw J; Urnes M; Grosmaire L; Ledbetter JA
J Immunol; 1993 Apr; 150(8 Pt 1):3161-9. PubMed ID: 7682233
[TBL] [Abstract][Full Text] [Related]
62. Role and expression of CD40 on human retinal pigment epithelial cells.
Willermain F; Caspers-Velu L; Baudson N; Dubois C; Hamdane M; Willems F; Velu T; Bruyns C
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3485-91. PubMed ID: 11006243
[TBL] [Abstract][Full Text] [Related]
63. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway.
McLellan AD; Sorg RV; Williams LA; Hart DN
Eur J Immunol; 1996 Jun; 26(6):1204-10. PubMed ID: 8647193
[TBL] [Abstract][Full Text] [Related]
64. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
Biburger M; Weth R; Wels WS
J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
[TBL] [Abstract][Full Text] [Related]
65. Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis.
Shi FD; He B; Li H; Matusevicius D; Link H; Ljunggren HG
Eur J Immunol; 1998 Nov; 28(11):3587-93. PubMed ID: 9842901
[TBL] [Abstract][Full Text] [Related]
66. Inhibition of the CD40-CD40ligand pathway prevents murine membranous glomerulonephritis.
Biancone L; Andres G; Ahn H; DeMartino C; Stamenkovic I
Kidney Int; 1995 Aug; 48(2):458-68. PubMed ID: 7564113
[TBL] [Abstract][Full Text] [Related]
67. CD40-CD40L interactions in atherosclerosis.
Laman JD; de Smet BJ; Schoneveld A; van Meurs M
Immunol Today; 1997 Jun; 18(6):272-7. PubMed ID: 9190112
[No Abstract] [Full Text] [Related]
68. Design, Synthesis, and Evaluation of Novel Immunomodulatory Small Molecules Targeting the CD40⁻CD154 Costimulatory Protein-Protein Interaction.
Bojadzic D; Chen J; Alcazar O; Buchwald P
Molecules; 2018 May; 23(5):. PubMed ID: 29751636
[TBL] [Abstract][Full Text] [Related]
69. Nerve growth factor released by CD40 ligand-transfected l cells: implications for functional and phenotypic studies on CD40+ cells.
De Milito A; Nagy N; Samuelsson A; Chiodi F; Rajnavölgyi E
Blood; 1998 Dec; 92(11):4482-4. PubMed ID: 9882099
[No Abstract] [Full Text] [Related]
70. Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions.
Alberti D; Guarniero M; Maciola AK; Dotta E; Pasqual G
Curr Protoc; 2021 Dec; 1(12):e311. PubMed ID: 34870906
[TBL] [Abstract][Full Text] [Related]
71. Hyaluronic acid modulates glioma cell proliferation through its interaction with CD44H in vitro.
Koochekpour S; Pilkington G
Oncol Rep; 1996 Jan; 3(1):133-5. PubMed ID: 21594330
[TBL] [Abstract][Full Text] [Related]
72. Increased expression of surface CD44 in hypoxia-DCs skews helper T cells toward a Th2 polarization.
Yang M; Liu Y; Ren G; Shao Q; Gao W; Sun J; Wang H; Ji C; Li X; Zhang Y; Qu X
Sci Rep; 2015 Sep; 5():13674. PubMed ID: 26323509
[TBL] [Abstract][Full Text] [Related]
73. Differences in CD44 Surface Expression Levels and Function Discriminates IL-17 and IFN-γ Producing Helper T Cells.
Schumann J; Stanko K; Schliesser U; Appelt C; Sawitzki B
PLoS One; 2015; 10(7):e0132479. PubMed ID: 26172046
[TBL] [Abstract][Full Text] [Related]
74. Why can't the immune system control HIV-1? Defining HIV-1-specific CD4+ T cell immunity in order to develop strategies to enhance viral immunity.
Ostrowski MA; Yu Q; Yue FY; Liu J; Jones B; Gu XX; Loutfy M; Kovacs CM; Halpenny R
Immunol Res; 2006; 35(1-2):89-102. PubMed ID: 17003512
[TBL] [Abstract][Full Text] [Related]
75. Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis.
Termeer C; Averbeck M; Hara H; Eibel H; Herrlich P; Sleeman J; Simon JC
Immunology; 2003 May; 109(1):32-40. PubMed ID: 12709015
[TBL] [Abstract][Full Text] [Related]
76. The transmembrane form of TNF-alpha drives autoantibody production in the absence of CD154: studies using MRL/Mp-Fas(lpr) mice.
Fujii T; Okada M; Mimori T; Craft J
Clin Exp Immunol; 2002 Nov; 130(2):224-32. PubMed ID: 12390309
[TBL] [Abstract][Full Text] [Related]
77. Nitric oxide limits the expansion of antigen-specific T cells in mice infected with the microfilariae of Brugia pahangi.
O'Connor RA; Devaney E
Infect Immun; 2002 Nov; 70(11):5997-6004. PubMed ID: 12379675
[TBL] [Abstract][Full Text] [Related]
78. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation.
Cuff CA; Kothapalli D; Azonobi I; Chun S; Zhang Y; Belkin R; Yeh C; Secreto A; Assoian RK; Rader DJ; Puré E
J Clin Invest; 2001 Oct; 108(7):1031-40. PubMed ID: 11581304
[TBL] [Abstract][Full Text] [Related]
79. Inhibition of the function of the FcgammaRIIB by a monoclonal antibody to thymic shared antigen-1, a Ly-6 family antigen.
Ding L; Shevach EM
Immunology; 2001 Sep; 104(1):28-36. PubMed ID: 11576217
[TBL] [Abstract][Full Text] [Related]
80. Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7).
Wittig BM; Johansson B; Zöller M; Schwärzler C; Günthert U
J Exp Med; 2000 Jun; 191(12):2053-64. PubMed ID: 10859330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
